Analyst Jason McCarthy holds a meeting with management, April 22-23 hosted by Maxim.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GANX:
- Reiterating Buy on Gain Therapeutics: Promising GT-02287 Parkinson’s Data and Diversified GCase Pipeline Support $8 Target
- Gain Therapeutics reports Q4 EPS (61c), consensus (14c)
- Gain Therapeutics Reports Promising GT-02287 Parkinson’s Data
- Gain announces presentations on Phase 1b clinical study of GT-02287
- Gain Therapeutics, Inc. (GANX) Q4 Earnings Cheat Sheet